Entzündliche Herzerkrankungen in der Notaufnahme

Entzündliche Erkrankungen des Herzens können alle Schichten des Herzens betreffen: das Endokard und die Herzklappen (Endokarditis), den Herzmuskel (Myokarditis) und den Herzbeutel (Perikarditis). Es handelt sich um ernstzunehmende Erkrankungen, die unbehandelt schwere Komplikationen mit sich bringen können. In der Notaufnahme gilt es daher, die richtige Verdachtsdiagnose zu stellen und eine rasche strukturierte Diagnostik in die Wege zu leiten.

Schlüsselwörter

Entzündliche Herzerkrankungen - infektiöse Endokarditis - Diagnostik - Therapie - Aufnahme-Triage

Publikationsverlauf

Artikel online veröffentlicht:
13. Oktober 2021

• Literatur

• 1 Habib G, Hoen B, Tornos P. et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 2009; 30: 2369-2413 DOI: 10.1093/eurheartj/ehp285. (PMID: 19713420)
• 2 Hitzenbichler F, Olic J, Hanses F. et al. Aktuelle Therapie der Endokarditis. Internist 2019; 60: 1111-1117 DOI: 10.1007/s00108-019-00664-4. (PMID: 31444523)
• 3 Habib G, Lancellotti P, Antunes MJ. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128 DOI: 10.1093/eurheartj/ehv319. (PMID: 26320109)
• 4 Sandoe JA, Barlow G, Chambers JB. et al. Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother 2015; 70: 325 DOI: 10.1093/jac/dku383. (PMID: 25355810)
• 5 Al-Nawas B, Block M, Ertl G. et al. Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infektiösen Endokarditis [Neuauflage 2009]. Kardiologe 2010; 4: 285-294 DOI: 10.1007/s12181-010-0282-2.
• 6 Caforio ALP, Pankuweit S, Arbustini E. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 2636-2648 DOI: 10.1093/eurheartj/eht210. (PMID: 23824828)
• 7 Adler Y, Charron P, Imazio M. et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36: 2921-2964 DOI: 10.1093/eurheartj/ehv318. (PMID: 26320112)
• 8 Dreger H, Haug M, Möckel M. Dressler syndrome in anterior wall infarction following traumatic coronary artery dissection. Dtsch Ärztebl Int 2019; 116: 562 DOI: 10.3238/arztebl.2019.0562. (PMID: 31554547)
• 9 Kaushik M, Sontineni SP, Hunter C. Cardiovascular disease and androgens: a review. Int J Cardiol 2010; 142: 8-14 DOI: 10.1016/j.ijcard.2009.10.033. (PMID: 19923015)
• 10 Klinikleitfaden Kardiologie. Stierle U. 6. Aufl. München: Elsevier; 2017
• 11 Lieback E, Hardouin I, Meyer R. et al. Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 1996; 17: 135-142 DOI: 10.1093/oxfordjournals.eurheartj.a014671. (PMID: 8682119)
• 12 Grün S, Schumm J, Greulich S. et al. Longterm follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604-1615 DOI: 10.1016/j.jacc.2012.01.007.
• 13 Caforio ALP, Adler Y, Agostini C. et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J 2017; 38: 2649-2662 DOI: 10.1093/eurheartj/ehx321. (PMID: 28655210)
• 14 Scott PA, Morgan JM, Carroll N. et al. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators. Circ Arrhythm Electrophysiol 2011; 4: 324-330 DOI: 10.1161/CIRCEP.110.959544. (PMID: 21493964)
• 15 Patriki D, Gresser E, Manka R. et al. Approximation of the Incidence of Myocarditis by Systematic Screening With Cardiac Magnetic Resonance Imaging. JACC Heart Fail 2018; 6: 573-579 DOI: 10.1016/j.jchf.2018.03.002. (PMID: 29885953)
• 16 Ponikowski P, Voors A, Anker S. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200 DOI: 10.1093/eurheartj/ehw128. (PMID: 27206819)
• 17 Schwab JO, Bänsch D, Israel C. et al. Stellungnahme zum Einsatz des tragbaren Kardioverter/Defibrillators. Kardiologe 2015; 9: 165-170 DOI: 10.1007/s12181-015-0651-y.
• 18 Peretto G, Sala S, Rizzo S. et al. Arrhythmias in Myocarditis: State of the Art. Heart Rhythm 2018; 16: 793-801 DOI: 10.1016/j.hrthm.2018.11.024. (PMID: 30476544)
• 19 Cooper L, Hare JM, Tazelaar HD. et al. Usefulness of Immunosuppression for Giant Cell Myocarditis. Am J Cardiol 2008; 102: 1535-1539 DOI: 10.1016/j.amjcard.2008.07.041. (PMID: 19026310)
• 20 Jakstaite AM, Papathanasiou M, Lüdike P. Myokarditis und COVID-19: Wo stehen wir?. Akt Kardiol 2021; 10: 27-31 DOI: 10.1055/a-1314-9200.